Zhengye Biotechnology Holding ZYBT
NASDAQ ZYBT
$1.46 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Zhengye Biotechnology Holding (ZYBT) Debt Ratio (2023 - 2025)

Updated

Zhengye Biotechnology Holding's Debt Ratio came in at 0.17 for the quarter ended Dec 31, 2025, down 2.4% from 0.18 a year earlier.

Analysis

Zhengye Biotechnology Holding (ZYBT) Debt Ratio (2023 - 2025) Analysis & Trends

Going back to the quarter ended Dec 31, 2023, Zhengye Biotechnology Holding's Debt Ratio data covers 4 quarters.

  • Going back by year, Debt Ratio was 0.18 in the year ended Dec 31, 2024 (-1.0%) and 0.18 in the year ended Dec 31, 2023.
  • The five-year range for quarterly Debt Ratio is 0.16 (the quarter ended Dec 31, 2023) to 0.18 (the quarter ended Dec 31, 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn 0.39
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn 0.23
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn 0.52
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn 0.42
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn 0.08
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn 0.28
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn 0.60
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn 0.53
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn 0.31
10 Zhengye Biotechnology Holding 68.66 Mn 56.94 Mn - 0.17
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 0.17
Jun 30, 2025 0.17
Dec 31, 2024 0.18
Dec 31, 2023 0.18
API Access

Zhengye Biotechnology Holding Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=ZYBT&period=max&api_key=YOUR_API_KEY